Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
The global anticoagulant market is highly competitive due to the presence of several international and regional vendors. The market has observed a high growth because of the increase in usage of NOACs and the growing number of surgeries worldwide. This has influx intense competition among the players in the NOACs market, which is emerging in the anticoagulant market. Also, the growing focus of established vendors in the emerging economies will likely change the market dynamics in the next four years.
In 2019, the market size of Anticoagulant is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anticoagulant.
This report studies the global market size of Anticoagulant, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anticoagulant sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Market Segment by Product Type
Oral
Injectable
Market Segment by Application
DVT
PE
AF
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anticoagulant status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anticoagulant manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anticoagulant are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
The global anticoagulant market is highly competitive due to the presence of several international and regional vendors. The market has observed a high growth because of the increase in usage of NOACs and the growing number of surgeries worldwide. This has influx intense competition among the players in the NOACs market, which is emerging in the anticoagulant market. Also, the growing focus of established vendors in the emerging economies will likely change the market dynamics in the next four years.
In 2019, the market size of Anticoagulant is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anticoagulant.
This report studies the global market size of Anticoagulant, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anticoagulant sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Market Segment by Product Type
Oral
Injectable
Market Segment by Application
DVT
PE
AF
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anticoagulant status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anticoagulant manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anticoagulant are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anticoagulant Market Size Growth Rate by Type (2019-2025)
1.3.2 Oral
1.3.3 Injectable
1.4 Market Segment by Application
1.4.1 Global Anticoagulant Market Share by Application (2019-2025)
1.4.2 DVT
1.4.3 PE
1.4.4 AF
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulant Market Size
2.1.1 Global Anticoagulant Revenue 2014-2025
2.1.2 Global Anticoagulant Sales 2014-2025
2.2 Anticoagulant Growth Rate by Regions
2.2.1 Global Anticoagulant Sales by Regions 2014-2019
2.2.2 Global Anticoagulant Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anticoagulant Sales by Manufacturers
3.1.1 Anticoagulant Sales by Manufacturers 2014-2019
3.1.2 Anticoagulant Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anticoagulant Revenue by Manufacturers (2014-2019)
3.2.2 Anticoagulant Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anticoagulant Market Concentration Ratio (CR5 and HHI)
3.3 Anticoagulant Price by Manufacturers
3.4 Key Manufacturers Anticoagulant Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anticoagulant Market
3.6 Key Manufacturers Anticoagulant Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oral Sales and Revenue (2014-2019)
4.1.2 Injectable Sales and Revenue (2014-2019)
4.2 Global Anticoagulant Sales Market Share by Type
4.3 Global Anticoagulant Revenue Market Share by Type
4.4 Anticoagulant Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anticoagulant Sales by Application
6 United States
6.1 United States Anticoagulant Breakdown Data by Company
6.2 United States Anticoagulant Breakdown Data by Type
6.3 United States Anticoagulant Breakdown Data by Application
7 European Union
7.1 European Union Anticoagulant Breakdown Data by Company
7.2 European Union Anticoagulant Breakdown Data by Type
7.3 European Union Anticoagulant Breakdown Data by Application
8 China
8.1 China Anticoagulant Breakdown Data by Company
8.2 China Anticoagulant Breakdown Data by Type
8.3 China Anticoagulant Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anticoagulant Breakdown Data by Company
9.2 Rest of World Anticoagulant Breakdown Data by Type
9.3 Rest of World Anticoagulant Breakdown Data by Application
9.4 Rest of World Anticoagulant Breakdown Data by Countries
9.4.1 Rest of World Anticoagulant Sales by Countries
9.4.2 Rest of World Anticoagulant Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anticoagulant
10.1.4 Anticoagulant Product Introduction
10.1.5 Bayer Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anticoagulant
10.2.4 Anticoagulant Product Introduction
10.2.5 Boehringer Ingelheim Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anticoagulant
10.3.4 Anticoagulant Product Introduction
10.3.5 Bristol-Myers Squibb Recent Development
10.4 Daiichi Sankyo
10.4.1 Daiichi Sankyo Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anticoagulant
10.4.4 Anticoagulant Product Introduction
10.4.5 Daiichi Sankyo Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anticoagulant
10.5.4 Anticoagulant Product Introduction
10.5.5 Pfizer Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anticoagulant
10.6.4 Anticoagulant Product Introduction
10.6.5 Johnson & Johnson Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anticoagulant
10.7.4 Anticoagulant Product Introduction
10.7.5 Sanofi Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anticoagulant
10.8.4 Anticoagulant Product Introduction
10.8.5 AstraZeneca Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anticoagulant
10.9.4 Anticoagulant Product Introduction
10.9.5 Eli Lilly Recent Development
10.10 Keryx Biopharmaceuticals
10.10.1 Keryx Biopharmaceuticals Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anticoagulant
10.10.4 Anticoagulant Product Introduction
10.10.5 Keryx Biopharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anticoagulant Sales Channels
11.2.2 Anticoagulant Distributors
11.3 Anticoagulant Customers
12 Market Forecast
12.1 Global Anticoagulant Sales and Revenue Forecast 2019-2025
12.2 Global Anticoagulant Sales Forecast by Type
12.3 Global Anticoagulant Sales Forecast by Application
12.4 Anticoagulant Forecast by Regions
12.4.1 Global Anticoagulant Sales Forecast by Regions 2019-2025
12.4.2 Global Anticoagulant Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anticoagulant Market Size Growth Rate by Type (2019-2025)
1.3.2 Oral
1.3.3 Injectable
1.4 Market Segment by Application
1.4.1 Global Anticoagulant Market Share by Application (2019-2025)
1.4.2 DVT
1.4.3 PE
1.4.4 AF
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulant Market Size
2.1.1 Global Anticoagulant Revenue 2014-2025
2.1.2 Global Anticoagulant Sales 2014-2025
2.2 Anticoagulant Growth Rate by Regions
2.2.1 Global Anticoagulant Sales by Regions 2014-2019
2.2.2 Global Anticoagulant Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anticoagulant Sales by Manufacturers
3.1.1 Anticoagulant Sales by Manufacturers 2014-2019
3.1.2 Anticoagulant Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anticoagulant Revenue by Manufacturers (2014-2019)
3.2.2 Anticoagulant Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anticoagulant Market Concentration Ratio (CR5 and HHI)
3.3 Anticoagulant Price by Manufacturers
3.4 Key Manufacturers Anticoagulant Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anticoagulant Market
3.6 Key Manufacturers Anticoagulant Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oral Sales and Revenue (2014-2019)
4.1.2 Injectable Sales and Revenue (2014-2019)
4.2 Global Anticoagulant Sales Market Share by Type
4.3 Global Anticoagulant Revenue Market Share by Type
4.4 Anticoagulant Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anticoagulant Sales by Application
6 United States
6.1 United States Anticoagulant Breakdown Data by Company
6.2 United States Anticoagulant Breakdown Data by Type
6.3 United States Anticoagulant Breakdown Data by Application
7 European Union
7.1 European Union Anticoagulant Breakdown Data by Company
7.2 European Union Anticoagulant Breakdown Data by Type
7.3 European Union Anticoagulant Breakdown Data by Application
8 China
8.1 China Anticoagulant Breakdown Data by Company
8.2 China Anticoagulant Breakdown Data by Type
8.3 China Anticoagulant Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anticoagulant Breakdown Data by Company
9.2 Rest of World Anticoagulant Breakdown Data by Type
9.3 Rest of World Anticoagulant Breakdown Data by Application
9.4 Rest of World Anticoagulant Breakdown Data by Countries
9.4.1 Rest of World Anticoagulant Sales by Countries
9.4.2 Rest of World Anticoagulant Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anticoagulant
10.1.4 Anticoagulant Product Introduction
10.1.5 Bayer Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anticoagulant
10.2.4 Anticoagulant Product Introduction
10.2.5 Boehringer Ingelheim Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anticoagulant
10.3.4 Anticoagulant Product Introduction
10.3.5 Bristol-Myers Squibb Recent Development
10.4 Daiichi Sankyo
10.4.1 Daiichi Sankyo Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anticoagulant
10.4.4 Anticoagulant Product Introduction
10.4.5 Daiichi Sankyo Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anticoagulant
10.5.4 Anticoagulant Product Introduction
10.5.5 Pfizer Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anticoagulant
10.6.4 Anticoagulant Product Introduction
10.6.5 Johnson & Johnson Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anticoagulant
10.7.4 Anticoagulant Product Introduction
10.7.5 Sanofi Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anticoagulant
10.8.4 Anticoagulant Product Introduction
10.8.5 AstraZeneca Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anticoagulant
10.9.4 Anticoagulant Product Introduction
10.9.5 Eli Lilly Recent Development
10.10 Keryx Biopharmaceuticals
10.10.1 Keryx Biopharmaceuticals Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anticoagulant
10.10.4 Anticoagulant Product Introduction
10.10.5 Keryx Biopharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anticoagulant Sales Channels
11.2.2 Anticoagulant Distributors
11.3 Anticoagulant Customers
12 Market Forecast
12.1 Global Anticoagulant Sales and Revenue Forecast 2019-2025
12.2 Global Anticoagulant Sales Forecast by Type
12.3 Global Anticoagulant Sales Forecast by Application
12.4 Anticoagulant Forecast by Regions
12.4.1 Global Anticoagulant Sales Forecast by Regions 2019-2025
12.4.2 Global Anticoagulant Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
